We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+4.86%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$667B
AUM Growth
-$78.5B
Cap. Flow
-$15B
Cap. Flow %
-2.25%
Top 10 Hldgs %
32.39%
Holding
14,586
New
1,953
Increased
4,555
Reduced
6,197
Closed
1,571

Top Buys

Rank Stock Value
1
C icon
Citigroup
C
+$1.13B
2
T icon
AT&T
T
+$275M
3
AAPL icon
Apple
AAPL
+$248M
4
DIS icon
Walt Disney
DIS
+$235M
5
NKE icon
Nike
NKE
+$195M

Sector Composition

Rank Sector Weight
1 Miscellaneous 92.82%
2 Technology 1.6%
3 Consumer Discretionary 1.3%
4 Financials 0.99%
5 Communication Services 0.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZYNE
11851
CALL
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$135K ﹤0.01%
46,900
-154,900
-77% -$573K
AAQC
11852
DELISTED
Accelerate Acquisition Corp
AAQC
$135K ﹤0.01%
13,934
-1,720
-11% -$16.8K
ESRT icon
11853
CALL
Empire State Realty Trust
ESRT
$795M
$134K ﹤0.01%
+15,100
New +$149K
IRON icon
11854
Disc Medicine
IRON
$3.07B
$134K ﹤0.01%
1,539
-1,805
-54% -$177K
OPFI icon
11855
PUT
OppFi
OPFI
$602M
$134K ﹤0.01%
29,500
+12,900
+78% +$77.7K
PPBT
11856
Purple Biotech
PPBT
$2.73M
$134K ﹤0.01%
+172
New +$147K
YCBD icon
11857
PUT
cbdMD
YCBD
$5.6M
$134K ﹤0.01%
346
-118
-25% -$68.6K
PVLA
11858
CALL
Palvella Therapeutics
PVLA
$2.16B
$134K ﹤0.01%
444
-210
-32% -$67.3K
DNA.WS
11859
DELISTED
Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share
DNA.WS
$134K ﹤0.01%
60,035
+16,360
+37% +$52.9K
AFIB
11860
DELISTED
Acutus Medical Inc
AFIB
$134K ﹤0.01%
39,159
-49,218
-56% -$277K
LTRPA
11861
CALL
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
$134K ﹤0.01%
61,700
-88,700
-59% -$250K
IVC
11862
PUT
DELISTED
Invacare Corporation
IVC
$134K ﹤0.01%
49,100
+8,700
+22% +$32.1K
REV
11863
PUT
DELISTED
Revlon, Inc.
REV
$134K ﹤0.01%
+11,800
New +$137K
AQMS icon
11864
Aqua Metals
AQMS
$9.7M
$133K ﹤0.01%
538
-95
-15% -$33.5K
ASMB icon
11865
Assembly Biosciences
ASMB
$694M
$133K ﹤0.01%
4,750
+1,759
+59% +$57.7K
BRFS
11866
DELISTED
BRF SA
BRFS
$133K ﹤0.01%
32,420
-152,548
-82% -$623K
CRESY
11867
CALL
Cresud
CRESY
$784M
$133K ﹤0.01%
29,248
-11,553
-28% -$55.7K
QNTM
11868
Quantum Biopharma Class B Subordinate Voting Shares
QNTM
$129
$133K ﹤0.01%
1,975
-860
-30% -$74.6K
BSGA
11869
DELISTED
Blue Safari Group Acquisition Corp. Class A Ordinary Share
BSGA
$133K ﹤0.01%
+13,329
New +$134K
ADTX
11870
CALL
DELISTED
ADITXT INC
ADTX
0
CSTE icon
11871
CALL
Caesarstone
CSTE
$109M
$132K ﹤0.01%
11,600
-19,200
-62% -$230K
KVHI icon
11872
KVH Industries
KVHI
$136M
$132K ﹤0.01%
14,353
-779
-5% -$7.82K
MVO
11873
PUT
DELISTED
MV Oil Trust
MVO
$132K ﹤0.01%
+14,900
New +$127K
PRPO icon
11874
Precipio
PRPO
$51.6M
$132K ﹤0.01%
+4,154
New +$178K
QUAD icon
11875
PUT
Quad
QUAD
$519M
$132K ﹤0.01%
32,900
+19,800
+151% +$81.1K

Similar funds

Jeff Yass's Q4 2021 Portfolio in Review

As of Q4 2021, Jeff Yass held 14,586 positions worth $667B, down 11% from $745B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Jeff Yass's Q4 2021 filing shows 1,953 new, 4,555 increased, 6,197 reduced and 1,571 closed positions. Its largest new stake was iShares Core MSCI Emerging Markets ETF: 1,306,619 shares worth $78.2M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $2.4B.

By sector, the portfolio is most concentrated in Miscellaneous at 93% of assets, up from 93% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Jeff Yass's largest Q4 2021 buy was iShares Core MSCI Emerging Markets ETF: 1,306,619 shares worth $78.2M.
  • Jeff Yass added most to Citigroup in Q4 2021, an estimated $1.13B increase.
  • Jeff Yass's biggest Q4 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.4B.
  • Jeff Yass fully exited Stamps.com, Inc. in Q4 2021, selling an estimated $78.8M.
  • Jeff Yass's ten largest holdings make up 32% of its $667B portfolio in Q4 2021.
  • Jeff Yass opened 1,953 new positions and closed 1,571 in Q4 2021.
  • Jeff Yass's portfolio value fell 11% quarter-over-quarter to $667B.

Based on Susquehanna International Group's 13F filing for Q4 2021, filed 14 Feb 2022.